EASTONBIOPHARMACEUTICALS(SH:688513) Ge Long Hui A P P·2025-09-28 07:48Core Viewpoint - Yuan Dong Biotech (688513.SH) announced that its wholly-owned subsidiary Chengdu Shuo De Pharmaceutical Co., Ltd. has received the Drug Registration Certificate approved by the National Medical Products Administration for its product, Ephedrine Hydrochloride Tablets [1] Group 1: Company Developments - Chengdu Shuo De Pharmaceutical has been granted approval for Ephedrine Hydrochloride Tablets, which is a significant milestone for the company [1] - The active ingredient of the tablets is Ephedrine Hydrochloride, indicating the company's focus on addressing various medical conditions [1] Group 2: Product Indications - The primary indications for Ephedrine Hydrochloride Tablets include improving muscle tension states in conditions such as cervical shoulder-arm syndrome, periarthritis of the shoulder, and low back pain [1] - The product is also indicated for spastic paralysis caused by cerebrovascular disorders, spastic myelitis, cervical spondylosis, postoperative sequelae, and other neurological conditions [1]